ClinicalTrials.govpublic full text
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas
basal cell carcinomas, gorlin syndrome, basal cell nevus syndrome bcns, nevoid basal cell carcinoma syndrome, basal cell carcinoma, hedgehog inhibitor, surgically eligible basal cell carcinomas, high frequency basal cell carcinomas, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866869
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.